Acute angle-closure glaucoma following botulinum toxin injection for blepharospasm.
نویسندگان
چکیده
منابع مشابه
Acute angle-closure glaucoma following botulinum toxin injection for blepharospasm.
Botulinum toxin inhibits acetylcholine release and therefore could cause mydriasis. We report a case of acute angle-closure glaucoma which occurred shortly after a series of injections of botulinum toxin round the eyelids for blepharospasm.
متن کاملAcute angle closure following periorbital botulinum toxin injection in a patient with retinitis pigmentosa
A 50-year-old female presented with bilateral retinitis pigmentosa (RP) and acute angle closure (AAC) with fixed mid-dilated pupil and high intraocular pressure (IOP) in the left eye following left side periorbital botulinum toxin A injection for blepharospasm. Glaucomatous optic neuropathy and retinal nerve fiber layer defect were observed in the affected eye using optical coherence tomography...
متن کاملBilateral acute angle-closure glaucoma following tramadol subcutaneous administration
BACKGROUND To report a case of bilateral acute angle closure-glaucoma following the use of subcutaneous Tramadol. CASE PRESENTATION A 42-year-old healthy man with unremarkable past medical and ocular history, was admitted to the Orthopedic Department for surgical treatment of a bilateral open fracture of the femur following a road accident. Three hoursafterTramadolsubcutaneous injection, the ...
متن کاملIntermittent acute angle closure glaucoma and chronic angle closure following topiramate use with plateau iris configuration
This is a case report describing recurrent intermittent acute angle closure episodes in the setting of topiramate use in a female suffering from migraines. Despite laser peripheral iridotomy placement for the pupillary block component, and the discontinuation of topiramate, the acute angle closure did not resolve in the left eye with chronic angle closure and the patient required urgent trabecu...
متن کاملNeuralgic amyotrophy following botulinum toxin injection.
Botulinum toxin (BT) is a polypeptidic neurotoxin produced by Clostridium botulinum that is widely used in medicine [1]. The U.S. Food and Drug Administration (FDA) approved BT type A injection use for the treatment of cervical dystonia, blepharospasm, primary axillary hyperhydrosis and cosmetic use for glabellar lines, and it is also widely used to treat spasticity, siallorhea, chronic tension...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: British Journal of Ophthalmology
سال: 1990
ISSN: 0007-1161
DOI: 10.1136/bjo.74.5.309